6
Participants
Start Date
October 31, 2014
Primary Completion Date
July 31, 2017
Study Completion Date
October 31, 2017
mesenchymal stem cells
After preferred conditioning regimen for the patient, cyclophosphamide 50 mg/kg/day will be administered at +3 and +4 post transplant day. At +6 post transplant day, 2-8x10\^8 cell/kg mesenchymal stem cells will be infused.
cyclophosphamide administration
After preferred conditioning regimen for the patient, cyclophosphamide 50 mg/kg/day will be administered at +3 and +4 post transplant day.
Ankara University School of Medicine Department of Hematology, Ankara
The Scientific and Technological Research Council of Turkey
OTHER
Ankara University
OTHER